SCHEMBL29635403

SCHEMBL29635403

Cn1c(=O)n(CC(=O)N2CC(F)(F)C2)c2cc(-c3ccc(Cl)c(OC(F)F)c3)cnc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 20/20 1.00
GRIN2B Q13224 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20130216 1.00 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL20130213 0.91 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL29635465 0.91 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL29635438 0.90 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL20130214 0.90 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL29635392 0.88 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL20130215 0.88 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL20129953 0.86 GRIN1 (0.81) GRIN1GRIN2B
SCHEMBL31008693 0.86 GRIN1 (0.81) GRIN1GRIN2B
SCHEMBL20130209 0.84 GRIN1 (1.00) GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114989164-A Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-09-02 CN claimed
CN-110062761-B Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-05-13 CN claimed
CN-114989164-B Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2024-08-13 CN disclosed
CN-114989164-A Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-09-02 CN disclosed
CN-110062761-B Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-05-13 CN disclosed